Compare uniQure N.V. Ordinary Shares (QURE) vs Snap On Incorporated (SNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Snap On Incorporated — how do they compare? uniQure N.V. Ordinary Shares trades at $21.53 (market cap $1.45B), while Snap On Incorporated trades at $365.17 (market cap $18.80B). The key difference: Snap On Incorporated is far larger — about 13× uniQure N.V. Ordinary Shares's market cap, and Snap On Incorporated pays a 2.68% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Snap On Incorporated for 38 Days on average.
| QURE | SNA | |
|---|---|---|
Market Cap | $1.45B | $18.80B |
Volume | 3,323,243 | 214,829 |
Sector | Health | Industrials |
52-Week High | $70.59 | $419.31 |
52-Week Low | $9.03 | $328.69 |
Typical Hold Time | 0 Days | 38 Days |
Enterprise Value | $707.46M | $18.44B |
Dividend Yield | — | 2.68% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Snap-On Incorporated (SNA) trades at $363.67, up 0.46% on the day, with a bearish technical signal from moving averages. The company maintains strong profitability with a 19.6% net income margin and a 17.58% ROE. Recent earnings have been mixed, with Q2 2026 beating estimates but Q1 2026 missing. Analyst consensus is bullish with a $449 price target, though technical indicators suggest near-term caution amid institutional positioning shifts.
The outlook for SNA is supported by solid fundamentals and analyst optimism, but faces headwinds from technical bearishness and valuation risks. Upside potential exists if earnings momentum continues, while risks include execution challenges and market volatility. The stock's premium valuation requires sustained growth to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Snap On Incorporated
Snap-on Incorporated is a leading global innovator, manufacturer, and marketer of tools, equipment, diagnostics, repair information, and systems solutions for professional users. Its products are widely used in vehicle service and repair, as well as in other demanding industrial environments. The company is best known for its premium tool brand, often sold through a network of franchised mobile stores, and is a primary supplier to technicians in the transportation industry.
Read more on SNA →
